![Amy Peterson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 23 M $ in data 31/05/2026
Amy C.
Peterson is currently Secretary & Director at Conquer Cancer Foundation of the American Society of Clinical.
Formerly, Dr. Peterson was Associate Group Medical Director at Genentech, Inc. from 2005 to 2011, Vice President-Clinical Development at Medivation LLC (California) from 2011 to 2016, Chief Medical Officer-Immuno-Oncology at BeOne Medicines Ltd. from 2016 to 2019, President & Chief Operating Officer at CytomX Therapeutics, Inc. in 2022, and Chief Medical Officer & Executive Vice President at Exelixis, Inc. from 2023 to 2025.
Education includes a doctorate from Thomas Jefferson University and an undergraduate degree from Wesleyan University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
EXELIXIS, INC. 0,19% | 16/05/2025 | 465.393 ( 0,19% ) | 23 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
Conquer Cancer Foundation of the American Society of Clinical
 Conquer Cancer Foundation of the American Society of Clinical Miscellaneous Commercial ServicesCommercial Services Improves cancer care and prevention | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| EXELIXIS, INC. | Direttore Tecnico/Scientifico/R&S | 29/08/2025 |
| CYTOMX THERAPEUTICS, INC. | Presidente | 12/09/2022 |
| BEIGENE LTD | Direttore Tecnico/Scientifico/R&S | 23/01/2019 |
| MEDIVATION INC | Corporate Officer/Principal | 01/07/2016 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/01/2011 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Thomas Jefferson University
 Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Wesleyan University
 Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
Conquer Cancer Foundation of the American Society of Clinical
Conquer Cancer Foundation of the American Society of Clinical Miscellaneous Commercial ServicesCommercial Services Improves cancer care and prevention | Commercial Services |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
